Report : Asia Pacific Infertility Treatment Devices and Equipment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Ovum Aspiration Pumps, Sperm Separation Devices, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, and Others); Procedure (Assisted Reproductive Technology, Artificial Insemination, and Fertility Surgery); End User (Fertility Clinics, Hospitals and Other Healthcare Facilities, and Clinical Research Institutes) and Country
Artificial Insemination Segment Held Largest Share of Procedure in Asia Pacific Infertility Treatment Devices and Equipment Market in 2019
According to a new market research study of ‘Asia Pacific Infertility Treatment Devices and Equipment Market Forecast to 2027 - COVID-19 Impact and Analysis by product, procedure, and end-user’ the Asia Pacific infertility treatment devices and equipment market is expected to reach US$ 386.64 million in 2027 from US$ 197.90 in 2019. The market is estimated to grow with a CAGR of 8.9% from 2020-2027. The report provides trends prevailing in the Asia Pacific infertility treatment devices and equipment market and the factors driving market along with those that act as hindrances.
Based on the procedure, the Asia Pacific the infertility treatment devices and equipment market, is segmented into assisted reproductive technology, artificial insemination, and fertility surgery. The artificial insemination segment held the largest share of the market in 2019, whereas the assisted reproductive technology segment is anticipated to register the highest CAGR in the market during the forecast period. Artificial insemination relates to the insertion of sperms directly into the woman’s cervix, uterus, or fallopian tubes without sexual intercourse. The procedure is recommended when men’s sperm count is low or the sperms does not possess enough strength to travel through cervix. In case of women, endometriosis may lead to preference for artificial insemination. Significant success rate offered by artificial insemination is estimated to offer lucrative opportunity for the growth of the segment. Whereas, assisted reproductive technology is estimated to register the highest CAGR during the forecast period. Assisted reproductive technologies is one of the prominent method to treat infertility. In this technology, eggs from women are retrieved and fertilized with sperm, leading to embryo development. Once the embryo is developed, it again put back in woman’s uterus. In-vitro fertilization is widely recommended and accepted method amongst assisted reproductive technologies across the world.
The growth of this market is estimated to grow owing to key driving factors such as higher rate of infertility in men and women and urbanization and rapid development in the Asia Pacific region. However, lack of awareness regarding reproductive techniques in rural areas is likely to hamper the market growth.
Eppendorf AG, Cooper Surgical, Inc., and INVO Bioscience are among the leading companies operating in the Asia Pacific infertility treatment devices and equipment market.
Asia Pacific Infertility Treatment Devices and Equipment Market, By Country, 2019(% share)
The report segments Asia Pacific Infertility Treatment Devices and Equipment Market as Follows:
- Ovum Aspiration Pumps
- Sperm Separation Devices
- Sperm Analyzer Systems
- Micromanipulator Systems
- Assisted Reproductive Technology
- In Vitro Fertilization
- Intracytoplasmic Sperm Injection
- Artificial Insemination
- Intrauterine Insemination
- Intratubal Insemination
- Intracervical Insemination
- Fertility Surgery
- Tubal Ligation Reversal
- Fertility Clinics
- Hospitals and Other Healthcare Facilities
- Clinical Research Institutes
- Asia Pacific
- South Korea